par Baselga, José;Gómez, Patricia;Greil, Richard;Braga, Sofia ;Climent, Miguel Angel;Wardley, Andrew;Kaufman, Bella;Stemmer, Salomon M;Pêgo, António;Chan, Arlene;Goeminne, Jean Charles;Graas, Marie-Pascale;Kennedy, M John;Ciruelos Gil, Eva Maria;Schneeweiss, Andreas;Zubel, Angela;Groos, Jutta;Melezínková, Helena;Awada, Ahmad
Référence Journal of clinical oncology, 31, 20, page (2586-2592)
Publication Publié, 2013-07
Référence Journal of clinical oncology, 31, 20, page (2586-2592)
Publication Publié, 2013-07
Article révisé par les pairs
Résumé : | Epidermal growth factor receptor is overexpressed in metastatic triple-negative breast cancers (mTNBCs), an aggressive subtype of breast cancer. Our randomized phase II study investigated cisplatin with or without cetuximab in this setting. |